|
1. General information: Pedro Antonio López Saura, born at La Habana, on September 26, 1947; citizen of Cuba. Works at Centro de Ingenieria Genetica y Biotecnologia, La Habana, (Vice-Director for Regulations and Clinical Trials).
2. Titles: Dr. in Medicine (1969), Dr. in Biological Sciences (Ph.D.) (1978), Principal Researcher (1981), Second Degree Specialist in Clinical Biochemistry (1986), Full Member of the Cuban Academy of Sciences (1996 - 2002)
3. Trainings at: Physiological Chemistry Institute, Catholic University of Leuven (Prof. Christian de Duve), 1971- 1972; Physiological Chemistry Institute "Friedrich Schiller" University, Jena (Prof. Anton Horn); Pathobiochemistry Department, Erfurt Medical Academy (Prof. Klaus Thielmann) 1977; Central Public Health Laboratory, Helsinki, Finland; Prof. Kari Cantell, 1981 and 1984; Institute Curie, Paris, France; Studies on the Interferon System in patients, Prof. Ernesto Falcoff, 1984.
4. Professional experience: National Center for Scientific Research (CENIC): 1969 - 1981: Researcher, Head of Department, Member of the Scientific Council, Member of the Editorial Council of the journal "CENIC, Ciencias Biológicas". Center for Biological Research (CIB): Researcher; Vice-director for Production, (1982-1986); Director (1986-1989); Center for Genetic Engineering and Biotechnology (CIGB): Researcher, Vice-Director (1986-1989), Head of Division for Clinical Studies (1991 - 1997); Vice-Director for Regulations and Clinical Studies (1998 -)
Other activities: Focal point (now Liaison Officer) in Cuba of the International Center for Genetic Engineering and Biotechnology (1984 - ); Member of the Editorial Board of the journal "Interferon y Biotecnología" now "Biotecnología Aplicada", La Habana (1984- ); Secretary of the Tribunal for Researchers' Categorization, (1983 - 1996). President since 1996.; Member of the Scientific-Technical Advisory Council of the Public Health Minister, Cuba (1987- ); Member of the Scientific Council of the Cuban Academy of Sciences (1993 - 1996); Member of the Cuban Academy of Sciences (1996 -1998 and 1998 - 2002). President of the Publications Commission.; Member of the National Advisory Commission for Clinical Trials (Public Health Ministry, 1993 - ....)
5. Research subjects (in the last 5 years): Studies related to the Interferon System in treated patients and mechanism of action of interferons; clinical application of interferons and other biotechnology products; coordination and evaluation of clinical trials; regulatory aspects of Biotechnology products.
6. Participation in 176 scientific meetings, in Cuba or abroad and in 51 technical official missions abroad.
7. Teaching activity. Pre-graduate level: Biochemistry lectures to Medicine students, Faculty of Medicine, University of Havana (1969-1976); Clinical Biochemistry lectures to Biochemistry students. Faculty of Biology, University of Habana (1977-1979); direct tutorship to 5 Graduate Theses. Post-graduate level: Professor in postgraduate courses on Biochemistry, Cell Fractionation, Hereditary-metabolic Diseases, Quality Control in Clinical Laboratory, Production and Clinical Uses of Interferons, Good Clinical Practices and Standard Operation Procedures, Biological Response Modifiers, Fundamentals of Clinical Trials, Application of Biotechnological products in therapy, Design and Update of Clinical Trials, Update on Multiple Sclerosis; Direct tutorship to 4 M.D. Specialization (Biochemistry, Clinical Biochemistry and Epidemiology) and 3 Ph. D. theses; lectures on interferons, cytokines, clinical trials or related subjects in 56 institutions in several countries.
8. Scientific Societies: Cuban Society for Interferon Research (since 1983); President since 1993; International Society for Interferon Research (since 1988); Member of the International Council since 1992; International Transfer Factor Society (since 1997).
9. Patents and Inventions: 3 on: lysine production from yeast (1978); production of transfer factor (1987); and use of epidermal growth factor in acne (1995).
10. National annual awards of the Academy of Sciences for participation in results on interferon production, participation in the AIDS program, transfer factor production (1990), participation in the research on the epidemic neuropathy (1993), national extension of the use of recombinant streptokinase in cardiac infarct (1995), regulation of papillomavirus by interferon (1996), development of interferon gamma as immunomodulator (1998), use of interferon alpha in Peyronie's disease (1999), Papillomavirus-related angiogenesis in cervix carcinoma (2000), and the experimental basis for the parenteral use of EGF as cytoprotective (2000). National awards of the Ministry for Public Health for participation in results on the effect of interferon alpha on HeLa cells phenotype (1993), and use of recombinant streptokinase in heart infarct. National Science and Technology Forum awards for participation in results on the use of transfer factor in acute leukemias (1993), recombinant streptokinase in heart infarct (1995), and the national program for the use of interferon in respiratory papillomatosis in Cuba (2001). Distinguished by the Council of State as founder of Biotechnology in Cuba (1996).
11. Publications: total: 181; in the last 5 years: 43. |
